White Paper: Optimizing Pharmaceutical Laboratory Instrument Management

In recent years, pharmaceutical development and manufacturers have joined a growing list of health care enterprises that are striving to reduce costs without compromising on quality. Few, however, have capitalized on an area of enormous benefit — the optimized management and maintenance of laboratory assets. This has been highlighted in Ernst and Young’s survey “The Pharmaceutical CFO’s Expanding Agenda”, which revealed that 76% of respondents wanted to prioritize internal business processes; 64% were planning on outsourcing several internal functions and 62% would be focusing on supplier costs.

A complete laboratory asset management program offers pharmaceutical and biotech companies:

• Exceptional inventory accuracy
• Improved service levels and uptime
• Increased scientific productivity
• Significant cost reductions, including savings through increased uptime and maintenance efficiency as well as “soft” savings as a result of employees spending less time managing scientific assets
• Enhanced decision-making and capital planning based on real-time asset data
• Robust, lower-cost compliance as a result of tailored quality systems and validation